Follistatin, endoglin predict postallogeneic HCT NRMFebruary 27, 2017Cellular TherapyPatient & Survivor Care
Palliative care improves quality of life after HCTJanuary 19, 2017Cellular TherapyPatient & Survivor Care
VIDEO: Despite toxicities, ibrutinib is beneficial for treatment-resistant graft-vs.-host diseaseJanuary 18, 2017Cellular TherapyPatient & Survivor Care
Worse outcomes for double-hit lymphomas after ASCTNovember 23, 2016Aggressive LymphomasCellular Therapy
Allogeneic stem cells show promise for treating nonischemic dilated cardiomyopathyNovember 21, 2016Cellular Therapy
Lenalidomide maintenance prolongs overall survival after ASCTJune 4, 2016Multiple MyelomaCellular Therapy
In myelodysplastic syndrome, improved tool for predicting death after HCTApril 11, 2016Myelodysplastic SyndromeAMLCellular Therapy
Cyclophosphamide nets low rate of chronic GVHD after mobilized blood cell transplantationApril 2, 2016Cellular TherapyCML
Drug for conditioning AML patients for transplant gets orphan drug designationMarch 31, 2016AMLCellular Therapy
Children who have stem cell transplants need skin exams, sun protectionMarch 7, 2016PediatricsCellular TherapyPatient & Survivor Care
